Alfonso Jesús
Domínguez-Gil Hurlé
Profesor Emérito Honorífico
José
Martínez Lanao
Catedrático de Universidad
Publicaciones en las que colabora con José Martínez Lanao (58)
2009
-
Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients
Journal of Pharmacy and Pharmacology, Vol. 61, Núm. 6, pp. 759-766
2004
-
Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates
Journal of Antimicrobial Chemotherapy, Vol. 54, Núm. 1, pp. 193-198
1999
-
Population pharmacokinetics of amikacin in patients with haematological malignancies
Journal of Antimicrobial Chemotherapy, Vol. 44, Núm. 2, pp. 235-242
1998
-
Influence of clinical diagnosis in the population pharmacokinetics of amikacin in intensive care unit patients
Clinical Drug Investigation, Vol. 15, Núm. 5, pp. 435-444
1997
-
Population pharmacokinetics of caffeine in premature neonates
European Journal of Clinical Pharmacology, Vol. 52, Núm. 3, pp. 211-217
-
Study on pharmacokinetics and nephrotoxicity of netilmicin in rabbits using a new dosage regimen
Methods and Findings in Experimental and Clinical Pharmacology, Vol. 19, Núm. 1, pp. 53-59
1996
-
Bayesian forecasting in paediatric populations
Clinical Pharmacokinetics
-
Influence of pharmacokinetic model on vancomycin peak concentration targets
Therapeutic Drug Monitoring, Vol. 18, Núm. 2, pp. 145-148
-
Pharmacokinetics of amikacin in intensive care unit patients
Journal of Clinical Pharmacy and Therapeutics, Vol. 21, Núm. 6, pp. 417-421
1995
-
Binding of roxithromycin to total plasma proteins, albumin, polymorphonuclear cells and lymphocytes
Revista Espanola de Quimioterapia, Vol. 8, Núm. 1, pp. 46-50
-
Determination of netilmicin in plasma by HPLC
Journal of Pharmaceutical and Biomedical Analysis, Vol. 13, Núm. 8, pp. 1059-1062
-
Uptake of antibiotics by phagocytic cells: Study methods and therapeutic implications
Revista Espanola de Quimioterapia, Vol. 8, Núm. 2, pp. 100-108
1992
-
A method for the calculation of bioavailability in slow release formulations in the presence of within-individual variability
International Journal of Pharmaceutics, Vol. 86, Núm. 2-3, pp. 123-130
-
LIMITACIONES ANALITICAS EN LA MONITORIZACION DE NIVELES SERICOS DE DIGOXINA
Farmacia Clinica, Vol. 9, Núm. 9, pp. 774-785
1991
-
Bioequivalence of a new formulation of flecainide acetate.
European journal of drug metabolism and pharmacokinetics, Vol. Spec No 3, pp. 216-220
1990
-
Effect of renal impairment on distribution of ofloxacin
Antimicrobial Agents and Chemotherapy, Vol. 34, Núm. 3, pp. 455-459
-
Evolución histórica de la biofarmacia y farmacocinética, una nueva disciplina farmacéutica
Industria farmacéutica: Equipos, procesos y tecnología, Núm. 2, pp. 151-156
-
Influence of a single dose of ethanol on the kinetics of valproic acid in rats
Drug Metabolism and Disposition, Vol. 18, Núm. 5, pp. 732-734
-
Optimization of dosage regimens of aminoglycoside antibiotics in the presence of beta-lactam agents by simulation techniques
Acta Pharmaceutica Jugoslavica, Vol. 40, Núm. 2 SUPPL. 1, pp. 301-308
1989
-
MODIFICACIONES EN LA CINETICA DEL CLOBAZAM EN MODELO EXPERIMENTAL DE ALCOHOLISMO CRONICO
Ciencia e Industria Farmaceutica, Vol. 8, Núm. 10-12, pp. 238-241